Status:
COMPLETED
Hypertension in Patients Hospitalized With COVID-19
Lead Sponsor:
Zhenhua Zen
Conditions:
COVID-19
Hypertension
Eligibility:
All Genders
18-100 years
Brief Summary
Some studies have shown that the main pathogenesis of patients with covid19 is related to ACE2 receptor. Lung is one of the main organs, and there are many ACE2 receptors in cardiovascular system. ACE...
Detailed Description
In December, 2019, a cluster of severe pneumonia cases of unknown cause emerged in Wuhan, China, with clinical presentations greatly resembling viral pneumonia1. Deep sequencing analysis from lower re...
Eligibility Criteria
Inclusion
- COVID-19 pneumonia patients diagnosed by WHO criteria
Exclusion
- Patients who were younger than 18 years.
- Patients whose entire stay lasted for less than 48 hours.
Key Trial Info
Start Date :
March 21 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 30 2020
Estimated Enrollment :
275 Patients enrolled
Trial Details
Trial ID
NCT04318301
Start Date
March 21 2020
End Date
March 30 2020
Last Update
April 29 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hankou Hospital
Hankou, Hubei, China, 430000